Tablets & Capsules

TC0121

Issue link: https://www.e-digitaleditions.com/i/1331851

Contents of this Issue

Navigation

Page 57 of 67

48 January/February 2021 Advertisement Tablets & Capsules CapsCanada Headquaters 3236 SW 30th Avenue Dania Beach, FL 33312 Email: info@capscanada.com Phone: 1 800 440 6470 Capscanada.com CapsCanada About CapsCanada CapsCanada ® , a Lyfe Group Co., is one of the world's leading manufactur- ers of high-quality empty hard capsules. The company offers customized solutions that solve complex product development challenges for the global pharmaceutical, nutraceutical and consumer health industries. With a presence in over 60 countries, CapsCanada also offers the advantages of strategic global distribution locations and full-service representation. Capabilities To take products from concept to commercialization, CapsCanada's com- prehensive capabilities include: • Design & Development • Manufacturing • Regulatory Support • Research and Development • 360° Technical Support CapsCanada's capsules are available in a full range of sizes, flavors, fin- ishes, printing options and custom colors. This ensures they provide maxi- mum recognition and impact by aligning with your brand aesthetic. Signature Brands K-CAPS ® — Designed for the health-conscious consumer, K-CAPS are made with 100% plant-derived material (HPMC) and free of preserva- tives, allergens and starches. K-CAPS capsules are also Non-GMO, Kosher and Halal certified. Suitable for a variety of oral dosage forms, including those that have moisture-sensitive formulations, K-CAPS offer a consistent high performance on filling machines that minimizes loss. G-CAPS ® — Made from high-quality gelatin from 100% bovine hide, G-CAPS are the preferred two-piece capsule for a wide selection of for- mulations in nutritional and pharmaceutical products. G-CAPS are free of GMOs and synthetic excipients and are Kosher and Halal certified. CapsCanada assures quality and efficacy while developing long-term, mutually beneficial customer partnerships.

Articles in this issue

Links on this page

Archives of this issue

view archives of Tablets & Capsules - TC0121